April 11, 2018
The brain continues to put up a fight even as neurodegenerative diseases like dementia damage certain areas and functions. In fact, recent findings in a Baycrest-University of Arizona study suggest that one method the brain uses to counter these diseases is the reassigning of tasks to different regions.
Patients diagnosed with Primary Progressive Aphasia (PPA), a rare form of dementia that robs a person of the ability to communicate, tapped into a different brain region to process the meaning of words, according to an article published in the journal Neuroimage: Clinical
. Typically people rely on the left side of the brain to comprehend words we read or hear, but PPA patients showed more brain activity on the right. These findings could be used to help develop targeted treatments to preserve brain function.
Previous studies have shown that this preservation tactic is used after brain damage, such as traumatic brain injury or stroke, but this is one of the first studies to demonstrate the phenomenon in a neurodegenerative disease.
“These findings offer hope since it demonstrates that despite the brain’s degeneration during PPA, it naturally adapts to try and preserve function,” says Dr. Jed Meltzer
, the senior author, a scientist at Baycrest’s Rotman Research Institute (RRI)
and Canada Research Chair in Interventional Cognitive Neuroscience
. “This compensation suggests there are opportunities to intervene and offer targeted treatment to those areas.”
The study captured brain imaging of 28 adults between the ages of 58 and 83, 13 of whom were diagnosed with PPA. While having their brains scanned, research participants were asked to read sentences that appeared on the screen, some of which had grammatical errors or mismatched words.
When a healthy adult processes the sentences with mistakes, there’s a spike in brain activity since the brain needs to work harder to make sense of it, says Dr. Meltzer, who is also an assistant professor in the departments of psychology and speech language pathology at the University of Toronto. People with PPA had greater difficulty detecting the mistakes and demonstrated a slower and smaller spike in brain activity when picking up on incorrect words, which could mean they weren’t processing them as thoroughly, says Dr. Meltzer. Those with PPA who performed better showed a larger response in the opposite side of the brain, the right, compared to healthy adults.
“We were able to identify regions of the brain that allowed the patients to compensate for the dying of neurons in the brain,” says Dr. Aneta Kielar
, assistant professor of speech, language and hearing sciences and of cognitive science at the University of Arizona, who did the work as a part of a postdoctoral fellowship at the RRI. She said knowing which areas of the brain people with PPA use to understand language may help in developing treatments.
The slower brain responses could also be used by doctors to assess the disease’s severity and lead to treatments being started even earlier, adds Dr. Meltzer.
As next steps, scientists are using this brain activity data to help treat PPA patients with targeted brain stimulation. Their work will also explore the short- and long-term effects of this intervention.
This work was supported by the Ontario Brain Institute, the Alzheimer’s Association, the Ontario Research Coalition and the Sandra A. Rotman Program in Cognitive Neuroscience. The research team also included Dr. Regina Jokel and Tiffany Deschamps.
With additional funding, researchers could explore launching a clinical trial to test brain stimulation treatments on more patients. Support Dr. Meltzer’s work by donating online or calling the donations line at 416-785-2875.
About Baycrest Health Sciences
Now in its 100th year, Baycrest Health Sciences is a global leader in geriatric residential living, healthcare, research, innovation and education, with a special focus on brain health and aging. Fully affiliated with the University of Toronto, Baycrest provides excellent care for older adults combined with an extensive clinical training program for the next generation of healthcare professionals and one of the world’s top research institutes in cognitive neuroscience, the Rotman Research Institute. Baycrest is home to the federally and provincially-funded Centre for Aging and Brain Health Innovation, a solution accelerator focused on driving innovation in the aging and brain health sector, and is the developer of Cogniciti – a free online memory assessment for Canadians 40+ who are concerned about their memory. Founded in 1918 as the Jewish Home for Aged, Baycrest continues to embrace the long-standing tradition of all great Jewish healthcare institutions to improve the well-being of people in their local communities and around the globe. For more information please visit: www.baycrest.org
About Baycrest’s Rotman Research Institute
The Rotman Research Institute at Baycrest Health Sciences is a premier international centre for the study of human brain function. Through generous support from private donors and funding agencies, the institute is helping to illuminate the causes of cognitive decline in seniors, identify promising approaches to treatment, and lifestyle practices that will protect brain health longer in the lifespan.
For media inquiries:
Baycrest Health Sciences
416-785-2500 ext. 5527
Michelle Petch Gotuzzo
Baycrest Health Sciences
416-785-2500 ext. 6932
Mari N. Jensen
University of Arizona